Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer

Hossein Borghaei, Ranee Mehra, George Simon

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

The CALGB 9633 study was designed to evaluate the efficacy of carboplatin and paclitaxel given in the adjuvant setting to patients with Stage IB non-small-cell lung cancer. Although interim analysis had shown clinical benefit, longer follow-up revealed lack of efficacy for this approach. We will examine the results of this trial in light of other positive adjuvant trials in patients with non-small-cell lung cancer.

Original languageEnglish
Pages (from-to)19-22
Number of pages4
JournalFuture Oncology
Volume5
Issue number1
DOIs
StatePublished - 2009

Keywords

  • Adjuvant chemotherapy
  • Carboplatin
  • Lung cancer
  • Paclitaxel

Fingerprint

Dive into the research topics of 'Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer'. Together they form a unique fingerprint.

Cite this